These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 34530383)

  • 21. Exploring Structure-Activity Relationship in Tacrine-Squaramide Derivatives as Potent Cholinesterase Inhibitors.
    Svobodova B; Mezeiova E; Hepnarova V; Hrabinova M; Muckova L; Kobrlova T; Jun D; Soukup O; Jimeno ML; Marco-Contelles J; Korabecny J
    Biomolecules; 2019 Aug; 9(8):. PubMed ID: 31430943
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 1H-1,2,3-triazole grafted tacrine-chalcone conjugates as potential cholinesterase inhibitors with the evaluation of their behavioral tests and oxidative stress in mice brain cells.
    Rani A; Singh A; Kaur J; Singh G; Bhatti R; Gumede N; Kisten P; Singh P; Sumanjit ; Kumar V
    Bioorg Chem; 2021 Sep; 114():105053. PubMed ID: 34120027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conjugates of tacrine and 1,2,4-thiadiazole derivatives as new potential multifunctional agents for Alzheimer's disease treatment: Synthesis, quantum-chemical characterization, molecular docking, and biological evaluation.
    Makhaeva GF; Kovaleva NV; Boltneva NP; Lushchekina SV; Rudakova EV; Stupina TS; Terentiev AA; Serkov IV; Proshin AN; Radchenko EV; Palyulin VA; Bachurin SO; Richardson RJ
    Bioorg Chem; 2020 Jan; 94():103387. PubMed ID: 31735356
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of bis(7)-tacrine, a novel anti-Alzheimer's agent, on rat brain AChE.
    Wang H; Carlier PR; Ho WL; Wu DC; Lee NT; Li CP; Pang YP; Han YF
    Neuroreport; 1999 Mar; 10(4):789-93. PubMed ID: 10208549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis, biological evaluation and molecular modeling study of novel tacrine-carbazole hybrids as potential multifunctional agents for the treatment of Alzheimer's disease.
    Thiratmatrakul S; Yenjai C; Waiwut P; Vajragupta O; Reubroycharoen P; Tohda M; Boonyarat C
    Eur J Med Chem; 2014 Mar; 75():21-30. PubMed ID: 24508831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heterodimeric tacrine-based acetylcholinesterase inhibitors: investigating ligand-peripheral site interactions.
    Carlier PR; Chow ES; Han Y; Liu J; El Yazal J; Pang YP
    J Med Chem; 1999 Oct; 42(20):4225-31. PubMed ID: 10514292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibitory effects of huperzine B on cholinesterase activity in mice.
    Liu J; Zhang HY; Wang LM; Tang XC
    Zhongguo Yao Li Xue Bao; 1999 Feb; 20(2):141-5. PubMed ID: 10437161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design and synthesis of novel tacrine-dipicolylamine dimers that are multiple-target-directed ligands with potential to treat Alzheimer's disease.
    Zhang P; Wang Z; Mou C; Zou J; Xie Y; Liu Z; Benjamin Naman C; Mao Y; Wei J; Huang X; Dong J; Yang M; Wang N; Jin H; Liu F; Lin D; Liu H; Zhou F; He S; Zhang B; Cui W
    Bioorg Chem; 2021 Nov; 116():105387. PubMed ID: 34628225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, synthesis and evaluation of novel 5,6,7-trimethoxyflavone-6-chlorotacrine hybrids as potential multifunctional agents for the treatment of Alzheimer's disease.
    Liao S; Deng H; Huang S; Yang J; Wang S; Yin B; Zheng T; Zhang D; Liu J; Gao G; Ma J; Deng Z
    Bioorg Med Chem Lett; 2015 Apr; 25(7):1541-5. PubMed ID: 25724825
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel tacrine-tryptophan hybrids: Multi-target directed ligands as potential treatment for Alzheimer's disease.
    Chalupova K; Korabecny J; Bartolini M; Monti B; Lamba D; Caliandro R; Pesaresi A; Brazzolotto X; Gastellier AJ; Nachon F; Pejchal J; Jarosova M; Hepnarova V; Jun D; Hrabinova M; Dolezal R; Zdarova Karasova J; Mzik M; Kristofikova Z; Misik J; Muckova L; Jost P; Soukup O; Benkova M; Setnicka V; Habartova L; Chvojkova M; Kleteckova L; Vales K; Mezeiova E; Uliassi E; Valis M; Nepovimova E; Bolognesi ML; Kuca K
    Eur J Med Chem; 2019 Apr; 168():491-514. PubMed ID: 30851693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design, synthesis, cholinesterase inhibition and molecular modelling study of novel tacrine hybrids with carbohydrate derivatives.
    Lopes JPB; Silva L; da Costa Franarin G; Antonio Ceschi M; Seibert Lüdtke D; Ferreira Dantas R; de Salles CMC; Paes Silva-Jr F; Roberto Senger M; Alvim Guedes I; Emmanuel Dardenne L
    Bioorg Med Chem; 2018 Nov; 26(20):5566-5577. PubMed ID: 30340901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and Cholinesterase Inhibitory Activity of N-Phosphorylated/ N-Tiophosphorylated Tacrine.
    Przybyłowska M; Inkielewicz-Stepniak I; Kowalski S; Dzierzbicka K; Demkowicz S; Daśko M
    Med Chem; 2020; 16(7):947-957. PubMed ID: 31309898
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tacrine Induces Endoplasmic Reticulum-Stressed Apoptosis via Disrupting the Proper Assembly of Oligomeric Acetylcholinesterase in Cultured Neuronal Cells.
    Liu EYL; Mak S; Kong X; Xia Y; Kwan KKL; Xu ML; Tsim KWK
    Mol Pharmacol; 2021 Nov; 100(5):456-469. PubMed ID: 34531295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tacrine-O-protected phenolics heterodimers as multitarget-directed ligands against Alzheimer's disease: Selective subnanomolar BuChE inhibitors.
    Roldán-Peña JM; Romero-Real V; Hicke J; Maya I; Franconetti A; Lagunes I; Padrón JM; Petralla S; Poeta E; Naldi M; Bartolini M; Monti B; Bolognesi ML; López Ó; Fernández-Bolaños JG
    Eur J Med Chem; 2019 Nov; 181():111550. PubMed ID: 31376562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of two different cholinesterases by tacrine.
    Ahmed M; Rocha JB; Corrêa M; Mazzanti CM; Zanin RF; Morsch AL; Morsch VM; Schetinger MR
    Chem Biol Interact; 2006 Aug; 162(2):165-71. PubMed ID: 16860785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis, biological evaluation, and molecular modeling studies of quinoline-ferulic acid hybrids as cholinesterase inhibitors.
    Mo J; Yang H; Chen T; Li Q; Lin H; Feng F; Liu W; Qu W; Guo Q; Chi H; Chen Y; Sun H
    Bioorg Chem; 2019 Dec; 93():103310. PubMed ID: 31586704
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potent Acetylcholinesterase Selective and Reversible Homodimeric Agent Based on Tacrine for Theranostics.
    Meena VK; Chaturvedi S; Sharma RK; Mishra AK; Hazari PP
    Mol Pharm; 2019 Jun; 16(6):2296-2308. PubMed ID: 31059278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, Synthesis and Evaluation of Novel Tacrine-Ferulic Acid Hybrids as Multifunctional Drug Candidates against Alzheimer's Disease.
    Fu Y; Mu Y; Lei H; Wang P; Li X; Leng Q; Han L; Qu X; Wang Z; Huang X
    Molecules; 2016 Oct; 21(10):. PubMed ID: 27727187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New racemic annulated pyrazolo[1,2-b]phthalazines as tacrine-like AChE inhibitors with potential use in Alzheimer's disease.
    Jalili-Baleh L; Nadri H; Moradi A; Bukhari SNA; Shakibaie M; Jafari M; Golshani M; Homayouni Moghadam F; Firoozpour L; Asadipour A; Emami S; Khoobi M; Foroumadi A
    Eur J Med Chem; 2017 Oct; 139():280-289. PubMed ID: 28803044
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and bioevaluation of new tacrine-cinnamic acid hybrids as cholinesterase inhibitors against Alzheimer's disease.
    Chen Y; Zhu J; Mo J; Yang H; Jiang X; Lin H; Gu K; Pei Y; Wu L; Tan R; Hou J; Chen J; Lv Y; Bian Y; Sun H
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):290-302. PubMed ID: 29278947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.